Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Herpes simplex virus blocks intracellular transport of HLA-G in placentally derived human cells.

Schust DJ, Hill AB, Ploegh HL.

J Immunol. 1996 Oct 15;157(8):3375-80.

PMID:
8871634
2.
3.

Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules.

Jun Y, Kim E, Jin M, Sung HC, Han H, Geraghty DE, Ahn K.

J Immunol. 2000 Jan 15;164(2):805-11.

4.

Interferon-gamma rescues HLA class Ia cell surface expression in term villous trophoblast cells by inducing synthesis of TAP proteins.

Rodriguez AM, Mallet V, Lenfant F, Arnaud J, Girr M, Urlinger S, Bensussan A, Le Bouteiller P.

Eur J Immunol. 1997 Jan;27(1):45-54.

PMID:
9021997
5.

HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells.

Nattermann J, Nischalke HD, Hofmeister V, Kupfer B, Ahlenstiel G, Feldmann G, Rockstroh J, Weiss EH, Sauerbruch T, Spengler U.

Antivir Ther. 2005;10(1):95-107.

PMID:
15751767
6.

Herpes simplex virus turns off the TAP to evade host immunity.

Hill A, Jugovic P, York I, Russ G, Bennink J, Yewdell J, Ploegh H, Johnson D.

Nature. 1995 Jun 1;375(6530):411-5.

PMID:
7760935
7.

Antigen processing and presentation by human trophoblast-derived cell lines.

Gobin SJ, Wilson L, Keijsers V, Van den Elsen PJ.

J Immunol. 1997 Apr 15;158(8):3587-92.

PMID:
9103419
8.

HLA-G and HLA-C at the feto-maternal interface: lessons learned from pathogenic viruses.

Schust DJ, Tortorella D, Ploegh HL.

Semin Cancer Biol. 1999 Feb;9(1):37-46. Review.

PMID:
10092549
9.
10.

The HLA-G*0105N null allele induces cell surface expression of HLA-E molecule and promotes CD94/NKG2A-mediated recognition in JAR choriocarcinoma cell line.

Sala FG, Del Moral PM, Pizzato N, Legrand-Abravanel F, Le Bouteiller P, Lenfant F.

Immunogenetics. 2004 Dec;56(9):617-24. Epub 2004 Nov 13.

PMID:
15578261
11.
12.

Preventing vaccinia virus class-I epitopes presentation by HSV-ICP47 enhances the immunogenicity of a TAP-independent cancer vaccine epitope.

Raafat N, Sadowski-Cron C, Mengus C, Heberer M, Spagnoli GC, Zajac P.

Int J Cancer. 2012 Sep 1;131(5):E659-69. doi: 10.1002/ijc.27362. Epub 2012 Jan 3.

13.

Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.

Rowe M, Khanna R, Jacob CA, Argaet V, Kelly A, Powis S, Belich M, Croom-Carter D, Lee S, Burrows SR, et al.

Eur J Immunol. 1995 May;25(5):1374-84.

PMID:
7774641
14.

Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10.

Salazar-Onfray F, Charo J, Petersson M, Freland S, Noffz G, Qin Z, Blankenstein T, Ljunggren HG, Kiessling R.

J Immunol. 1997 Oct 1;159(7):3195-202.

PMID:
9317117
15.

Processing of HIV-1 envelope glycoprotein for class I-restricted recognition: dependence on TAP1/2 and mechanisms for cytosolic localization.

Ferris RL, Hall C, Sipsas NV, Safrit JT, Trocha A, Koup RA, Johnson RP, Siliciano RF.

J Immunol. 1999 Feb 1;162(3):1324-32.

16.

Herpes simplex virus type 2 ICP47 inhibits human TAP but not mouse TAP.

Tomazin R, van Schoot NE, Goldsmith K, Jugovic P, Sempé P, Früh K, Johnson DC.

J Virol. 1998 Mar;72(3):2560-3.

17.
18.

Endoplasmic reticulum aminopeptidase-1 mediates leukemia inhibitory factor-induced cell surface human leukocyte antigen-G expression in JEG-3 choriocarcinoma cells.

Shido F, Ito T, Nomura S, Yamamoto E, Sumigama S, Ino K, Itakura A, Hattori A, Tsujimoto M, Mizutani S, Kikkawa F.

Endocrinology. 2006 Apr;147(4):1780-8. Epub 2006 Jan 26.

PMID:
16439450
19.

Expression of TAP1 by human trophoblast.

Clover LM, Sargent IL, Townsend A, Tampé R, Redman CW.

Eur J Immunol. 1995 Feb;25(2):543-53.

PMID:
7875218
20.

Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.

Romero JM, Jiménez P, Cabrera T, Cózar JM, Pedrinaci S, Tallada M, Garrido F, Ruiz-Cabello F.

Int J Cancer. 2005 Feb 10;113(4):605-10.

Supplemental Content

Support Center